![Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective | Psychiatrist.com Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/20com02677T1.gif)
Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective | Psychiatrist.com
![Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19](https://www.frontiersin.org/files/Articles/704767/fphar-12-704767-HTML/image_m/fphar-12-704767-t004.jpg)
Frontiers | High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa | PLOS ONE
Bioequivalence Study of Two Fixed Dose Combination Tablet Formulations of Lopinavir and Ritonavir in Healthy Volunteers
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
![Re: Acknowledgement of human bioequivalency of matrix's lopinavir–ritonavir formulation to Kaletra®, comment to article on bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al. - Re: Acknowledgement of human bioequivalency of matrix's lopinavir–ritonavir formulation to Kaletra®, comment to article on bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al. -](https://jpharmsci.org/cms/attachment/2046476358/2057584760/gr1.jpg)
Re: Acknowledgement of human bioequivalency of matrix's lopinavir–ritonavir formulation to Kaletra®, comment to article on bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al. -
![Lopinavir metered-dose transdermal spray through microporated skin: Permeation enhancement to achieve therapeutic needs - ScienceDirect Lopinavir metered-dose transdermal spray through microporated skin: Permeation enhancement to achieve therapeutic needs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224715001203-fx1.jpg)
Lopinavir metered-dose transdermal spray through microporated skin: Permeation enhancement to achieve therapeutic needs - ScienceDirect
![Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_social_default/public/2018-07/reduced-dose-darunavir-ritonavir-effective-and-safe-for-people-switching-while-virally-suppressed.jpg?itok=ZWEWUWgd)